Evaluating Neostigmine Effect on Reducing Gastric Residual Volume as Compared With Metoclopramide and Ondansetron
Clinical trial NCT05342818 · COMPLETED
Trial details
- NCT number
- NCT05342818
- Sponsor
- Tanta University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-15
- Primary completion
- 2022-07-30
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.